首页> 外文OA文献 >In vitro Antibacterial Activity of Mometasone Furoate, Fluticasone Propionate and Fluticasone Furoate Nasal Preparations Against Streptococcus pneumoniae, Hemophilus influenzae, Streptococcus viridans, Staphylococcus aureus, Pseudomonas aeruginosa, and Escherichia coli
【2h】

In vitro Antibacterial Activity of Mometasone Furoate, Fluticasone Propionate and Fluticasone Furoate Nasal Preparations Against Streptococcus pneumoniae, Hemophilus influenzae, Streptococcus viridans, Staphylococcus aureus, Pseudomonas aeruginosa, and Escherichia coli

机译:米多塞氏菌的体外抗菌活性,氟替卡松丙酸酯和氟替卡松染色鼻制鼻制鼻腔制剂,血糖流感嗜血杆菌,血管活性血清甘蓝甘肽,金黄色葡萄球菌,假单胞菌铜绿假单胞菌和大肠杆菌

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Objective: To test the antibacterial properties of three commercially available nasal corticosteroid preparations containing Mometasone Furoate (MF), Fluticasone Propionate (FP) and Fluticasone Furoate (FF) against S. pneumoniae, S. viridans, S. aureus, H. influenza, P. aeruginosa and E. coli.Methods: Study Design:  Experimental in vitro study using the disc diffusion method. Clinical isolates of Streptococcus pneumoniae, Hemophilus influenzae, Streptococcus viridans, Staphylococcus aureus, Pseudomonas aeruginosa, and Escherichia coli were inoculated on separate plates. 0.15 ml of nasal corticosteroid preparations containing MF, FP and FF were applied to blank paper discs, then placed on the plates, including an empty disc.  Following 24 and 48 hours of incubation, the inhibition zones were measured to the nearest mm from the point of abrupt inhibition of growth.Results: After 24 and 48 hours of incubation, S. pneumoniae, S. viridans, and S. aureus showed inhibition zones to all three preparations. S. aureus and S. viridans show the largest zones of inhibition at 24 and 48 hours respectively. H. influenza, P. aeruginosa and E. coli were negative. The inhibition zones of each bacteria were shown to be statistically different. The preparation containing FP had the largest zone of inhibition at 24 and 48 hours, although post hoc tests showed their difference was not significant.Conclusion: The present study demonstrates possible antimicrobial properties of commercially-available nasal corticosteroid preparations. However, it is unclear whether these can be attributed to the steroids, their excipients, or both. Further studies testing each component may offer better insights into their therapeutic use.Keywords: Mometasone Furoate, Fluticasone Propionate, Fluticasone Furoate, Antibacterial, Nasal Corticosteroids, Allergic Rhinitis, Acute Bacterial Rhinosinusitis
机译:目的:为了测试含有糠酸莫米松(MF),丙酸氟替卡松(FP)和糠酸氟替卡松(FF)针对肺炎链球菌,草绿色链球菌,金黄色葡萄球菌,流感嗜血杆菌,P三种市售鼻皮质类固醇制剂的抗菌特性铜绿假单胞菌和大肠杆菌。方法:研究设计:用纸片扩散法实验体外研究。肺炎链球菌,流感嗜血杆菌,草绿色链球菌,金黄色葡萄球菌,铜绿假单胞菌,和大肠杆菌临床分离株接种于单独的板。 0.15毫升含有MF,FP和FF鼻皮质类固醇制剂的施加到空白纸张的光盘,然后置于平板上,包括一个空的光盘。以下24和48小时孵育后,抑制区进行测量,从生长的抑制急剧的点最接近的毫米。结果:24和48小时的温育后,肺炎链球菌,草绿色链球菌,和金黄色葡萄球菌显示出抑制区到所有三种制剂。金黄色葡萄球菌和草绿色链球菌分别示出在24和48小时抑制的最大区域。流感嗜血杆菌,铜绿假单胞菌和大肠杆菌为阴性。各细菌的抑制区被证明是统计学差异。含有FP的制剂具有抑制的最大区域,在24和48小时,虽然事后测试显示其差异不显著。结论:本研究表明,市售的鼻皮质类固醇制剂可能的抗菌性能。但是,目前还不清楚是否这些可以归结为类固醇,它们的辅料,或两者兼而有之。进一步的研究检测各组件可以提供更好的洞察到他们的治疗用途。关键词:糠酸莫米松,丙酸氟替卡松,丙酸氟替卡松,抗菌,鼻皮质类固醇,过敏性鼻炎,急性鼻窦炎的细菌

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号